Yes, according to PricewarehouseCoopers, as the medical device sector looks to cope with the triple threat of a federal excise tax, pricing pressure and declining procedure volumes. Impending federal excise taxes, downward pricing pressure and declining volumes of big-ticket procedures constitute a triple threat that will drive the medical device industry to consolidate, according to a PricewaterhouseCoopers report. total value of health care deals over the past 12 months rose 40 percent, according to the consulting giant’s “U.S. Mid-Year M&A Outlook.” That trend is likely to continue, the report predicts.
